Immatics: T. Rowe Price reports 17.1% holding
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Immatics N.V. (IMTX) is the subject of a Schedule 13G amendment in which T. Rowe Price Investment Management, Inc. reports 25,149,155 common shares, or 17.1% of the class, as beneficially owned. It lists sole voting power over 25,109,257 shares and sole dispositive power over 25,149,155 shares, with shared voting and dispositive power of zero. T. Rowe Price Investment Management states that the report is not an admission of beneficial ownership and expressly denies being the beneficial owner.
Key Figures
Key Terms
beneficial ownership regulatory
Sole Voting Power regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.